HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pamela A DeLuca Selected Research

AT 112

4/2008Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pamela A DeLuca Research Topics

Disease

1Cardiovascular Diseases (Cardiovascular Disease)
04/2008
1Necrosis
04/2008
1Neoplasms (Cancer)
04/2008
1Abdominal Pain (Pain, Abdominal)
04/2008
1Myocardial Ischemia (Ischemic Heart Diseases)
04/2008

Drug/Important Bio-Agent (IBA)

1AT 112IBA
04/2008
1N-acetylcochinol-O-phosphateIBA
04/2008
1TroponinIBA
04/2008
1TubulinIBA
04/2008

Therapy/Procedure

1Intravenous Infusions
04/2008